Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07446218
What this trial is testing

Pharmacist-led Interventions in Psychiatric Patients

Who this might be right for
Mental DisordersMetabolic Syndrome
University of Lahore 148
Not applicableStudy completedNCT01075295
What this trial is testing

Prevention of Weight Gain in Early Psychoses

Who this might be right for
Schizophreniform DisorderBipolar I DisorderBipolar II Disorder+5 more
Centre for Addiction and Mental Health 70
Large-scale testing (Phase 3)Study completedNCT05110157
What this trial is testing

Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

Who this might be right for
Schizophrenia
Neurocrine Biosciences 442
Large-scale testing (Phase 3)Study completedNCT00236457
What this trial is testing

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 629
Large-scale testing (Phase 3)Study completedNCT01192867
What this trial is testing

RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 629
Large-scale testing (Phase 3)Ended earlyNCT01738698
What this trial is testing

Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 4
Large-scale testing (Phase 3)Study completedNCT01244815
What this trial is testing

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)

Who this might be right for
Bipolar Disorder, Pediatric
Organon and Co 404
Not applicableStudy completedNCT02085447
What this trial is testing

A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness

Who this might be right for
Psychotic DisordersSchizophreniaSchizoaffective Disorder+2 more
University Hospitals Cleveland Medical Center 30
Post-approval studies (Phase 4)Study completedNCT00331825
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Who this might be right for
SchizophreniaExtrapyramidal Syndrome
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 70
Post-approval studies (Phase 4)Study completedNCT00231894
What this trial is testing

Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

Who this might be right for
DiabetesSchizophreniaInsulin Resistance+1 more
Nathan Kline Institute for Psychiatric Research 56
Testing effectiveness (Phase 2)WithdrawnNCT05433402
What this trial is testing

Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer

Who this might be right for
Colon Cancer Stage III
Sadat City University
Post-approval studies (Phase 4)Study completedNCT00526877
What this trial is testing

An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

Who this might be right for
SchizophreniaSchizoaffective Disorders
Johnson & Johnson Taiwan Ltd 31
Large-scale testing (Phase 3)Study completedNCT01104766
What this trial is testing

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 617
Large-scale testing (Phase 3)Study completedNCT01716975
What this trial is testing

Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Who this might be right for
SchizophreniaImpaired Cognition
FORUM Pharmaceuticals Inc 767
Post-approval studies (Phase 4)Looking for participantsNCT05590637
What this trial is testing

Comparing Antipsychotic Medications in LBD Over Time

Who this might be right for
Parkinson's Disease PsychosisDementia With Lewy Bodies
The University of Texas Health Science Center at San Antonio 94
Not applicableStudy completedNCT01212575
What this trial is testing

A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 186
Post-approval studies (Phase 4)Study completedNCT00044655
What this trial is testing

Switching Medication to Treat Schizophrenia

Who this might be right for
Schizophrenia
Icahn School of Medicine at Mount Sinai 219
Large-scale testing (Phase 3)Study completedNCT00334126
What this trial is testing

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 399
Not applicableStudy completedNCT03389425
What this trial is testing

Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study

Who this might be right for
ObesityAbdominal Obesity
University of Calgary 9
Post-approval studies (Phase 4)Not Yet RecruitingNCT07386080
What this trial is testing

Carbergoline for Antipsychotic Induced Hyperprolactinemia.

Who this might be right for
Scizophrenia
Zealand University Hospital 146
Next Page